Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 February 2008, Vol. 111, No. 3, pp. 1686-1689.
Prepublished online as a Blood First Edition Paper on November 5, 2007November 6, 2007; DOI 10.1182/blood-2007-07-101576.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Methods, Table, and Figures
Right arrow All Versions of this Article:
blood-2007-07-101576v1
blood-2007-07-101576v2
111/3/1686    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pietra, D.
Right arrow Articles by Cazzola, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pietra, D.
Right arrow Articles by Cazzola, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted July 17, 2007
Accepted October 28, 2007

Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders

Daniela Pietra, Sai Li, Angela Brisci, Francesco Passamonti, Elisa Rumi, Alexandre Theocharides, Maurizio Ferrari, Heinz Gisslinger, Robert Kralovics, Laura Cremonesi, Radek Skoda, and Mario Cazzola*

Department of Hematology, Fondazione IRCCS Policlinico San Matteo & University of Pavia, Pavia, Italy
Department of Research, Experimental Hematology, Basel University Hospital, Basel, Switzerland
Genomic Unit for the Diagnosis of Human Pathologies, San Raffaele Scientific Institute, Milan, Italy
UniversitaVita-Salute San Raffaele, Milan, Italy
Department of Internal Medicine I, Division of Hematology & Blood Coagulation, Medical University of Vienna, Vienna, Austria
Center for Molecular Medicine, Austrian Academy of Sciences, Vienna, Austria
Diagnostica e Ricerca San Raffaele SpA, Milan, Italy

* Corresponding author; email: mario.cazzola{at}unipv.it.

We searched for JAK2 exon 12 mutations in patients with JAK2 (V617F)-negative myeloproliferative disorders. Seventeen patients with polycythemia vera (PV), including 15 sporadic cases and 2 familial cases, carried deletions or duplications of exon 12 in circulating granulocytes but not in T-lymphocytes. Two of the 8 mutations detected were novel, and the most frequent ones were N542-E543del and E543-D544del. Most patients with PV carrying an exon 12 mutations had isolated erythrocytosis at clinical onset, unlike patients with JAK2 (V617F)-positive PV, most of whom had also elevations in white blood cell and/or platelet counts. Both patients with familial PV carrying an exon 12 mutation had an affected sibling with JAK2 (V617F)-positive PV. Thus, several somatic mutations of JAK2 exon 12 can be found in a myeloproliferative disorder that is mainly characterized by erythrocytosis. Moreover, a genetic predisposition to acquisition of different JAK2 mutations is inherited in families with myeloproliferative disorders.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
L. Malcovati, M. G. Della Porta, D. Pietra, E. Boveri, A. Pellagatti, A. Galli, E. Travaglino, A. Brisci, E. Rumi, F. Passamonti, et al.
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
Blood, October 22, 2009; 114(17): 3538 - 3545.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Zhao, H. Dong, C. C. Zhang, L. Kinch, M. Osawa, M. Iacovino, N. V. Grishin, M. Kyba, and L. J.-s. Huang
A JAK2 Interdomain Linker Relays Epo Receptor Engagement Signals to Kinase Activation
J. Biol. Chem., September 25, 2009; 284(39): 26988 - 26998.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
J. H. Ohyashiki, H. Hisatomi, S. Shimizu, M. Sugaya, and K. Ohyashiki
Detection of Low Allele Burden of JAK2 Exon 12 Mutations Using TA-cloning in Patients with Erythrocytosis
Jpn. J. Clin. Oncol., August 1, 2009; 39(8): 509 - 513.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
I. Rapado, S. Grande, E. Albizua, R. Ayala, J.-A. Hernandez, M. Gallardo, F. Gilsanz, and J. Martinez-Lopez
High Resolution Melting Analysis for JAK2 Exon 14 and Exon 12 Mutations: A Diagnostic Tool for Myeloproliferative Neoplasms
J. Mol. Diagn., March 1, 2009; 11(2): 155 - 161.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
S. Schnittger, U. Bacher, C. Haferlach, T. Geer, P. Muller, J. Mittermuller, P. Petrides, R. Schlag, R. Sandner, J. Selbach, et al.
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
Haematologica, March 1, 2009; 94(3): 414 - 418.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
W. Ma, H. Kantarjian, X. Zhang, C.-H. Yeh, Z. J. Zhang, S. Verstovsek, and M. Albitar
Mutation Profile of JAK2 Transcripts in Patients with Chronic Myeloproliferative Neoplasias
J. Mol. Diagn., January 1, 2009; 11(1): 49 - 53.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
A. V. Jones, N. C.P. Cross, H. E. White, A. R. Green, and L. M. Scott
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis
Haematologica, October 1, 2008; 93(10): 1560 - 1564.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. L. Levine and D. G. Gilliland
Myeloproliferative disorders
Blood, September 15, 2008; 112(6): 2190 - 2198.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Sayyah, A. Magis, D. A. Ostrov, R. W. Allan, R. C. Braylan, and P. P. Sayeski
Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth
Mol. Cancer Ther., August 1, 2008; 7(8): 2308 - 2318.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
H. Bruchova, M. Merkerova, and J. T. Prchal
Aberrant expression of microRNA in polycythemia vera
Haematologica, July 1, 2008; 93(7): 1009 - 1016.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. A. Beer, P. J. Campbell, L. M. Scott, A. J. Bench, W. N. Erber, D. Bareford, B. S. Wilkins, J. T. Reilly, H. C. Hasselbalch, R. Bowman, et al.
MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
Blood, July 1, 2008; 112(1): 141 - 149.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
M. Cazzola
Molecular basis of thrombocytosis
Haematologica, May 1, 2008; 93(5): 646 - 648.
[Full Text] [PDF]


Home page
BloodHome page
R. Tiedt, H. Hao-Shen, M. A. Sobas, R. Looser, S. Dirnhofer, J. Schwaller, and R. C. Skoda
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
Blood, April 15, 2008; 111(8): 3931 - 3940.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Li, R. Kralovics, G. De Libero, A. Theocharides, H. Gisslinger, and R. C. Skoda
Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations
Blood, April 1, 2008; 111(7): 3863 - 3866.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
E. Hellstrom-Lindberg and M. Cazzola
The Role of JAK2 Mutations in RARS and Other MDS
Hematology, January 1, 2008; 2008(1): 52 - 59.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
C. James
The JAK2V617F Mutation in Polycythemia Vera and Other Myeloproliferative Disorders: One Mutation for Three Diseases?
Hematology, January 1, 2008; 2008(1): 69 - 75.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020